Life Expectancy in Autism Spectrum Disorder: Factors, Research & Outlook

Life Expectancy in Autism Spectrum Disorder (ASD): A Nuanced Picture

There is no single life expectancy for autism. Outcomes vary widely based on support needs, comorbidities, and access to care.

Key Research Findings

  • ASD without intellectual disability (ID): Life expectancy approaches general population (~70–80 yrs)
  • ASD with ID: Significantly reduced (studies report 39–61 yrs mean)
  • Major mortality drivers: Epilepsy, suicide, accidents, chronic disease (cardiovascular, respiratory), medication side effects
  • Sex differences: Females with ASD may have higher mortality risk

Landmark Studies

  • Hirvikoski et al. (2016, JAMA Psychiatry): Swedish cohort; ASD mean age at death 54 vs. 70 controls; ID subgroup 39.5 yrs
  • Guan & Li (2017, Autism Research): US data; ASD mean 36 yrs (but methodological limitations)
  • DaWalt et al. (2019, Autism): Premature mortality linked to health disparities, not autism per se

Modifiable Factors Improving Outcomes

  • Early diagnosis & intervention: Improves adaptive function, reduces comorbidities
  • Comprehensive healthcare: Regular screenings, epilepsy management, mental health
  • Suicide prevention: ASD ↑ suicidality 3–7×; screening, crisis planning
  • Accident prevention: Wandering, drowning, traffic safety
  • Transition planning: Pediatric → adult care continuity
  • Social inclusion: Employment, housing, community support

Critical Perspective

Reduced life expectancy reflects systemic gaps (healthcare access, diagnostic overshadowing, social determinants), not autism itself. With appropriate supports, many autistic adults live full lifespans.

Advocacy priorities: Healthcare equity, suicide prevention, safety, lifespan services.

Autism - Related Articles